Sponsored Research
Robert Lefkowitz of Cardiology has received an award (2R01-HL016037-51) from the National Institutes of Health for a project entitled "Molecular Regulation of Cardiovascular 7 TM Receptors." Total funding will be $2,844,377.
Howard Rockman of Cardiology has received an award (2R01-HL056687-26) from the National Institutes of Health for a project entitled "Mechanisms of Maladaptation in Heart Failure." Total funding will be $3,079,704.
Cathleen Colon-Emeric of Geriatrics has received an award (3UH3-AG056925-05S1) from the National Institutes of Health for a project entitled "Physical Resiliencies: Indicators and Mechanisms in the Elderly Collaborative (PRIME Collaborative)." Total funding will be $278,433.
Cara Mcdermott of Geriatrics has received a sub-award (5R33-AG057806-05) through the University of Massachusetts Medical School for a project entitled "Development of a Financial Toxicity Measurement Tool for Patients with Multimorbidity." Total funding will be $44,958.
Charity Oyedeji of Hematology has received an award (1K01-HL166369-01) from the National Institutes of Health for a project entitled "Sickle Cell Disease Functional Assessment Validation and Exercise Pilot Intervention." Total funding will be $798,338.
Wendy Prudhomme - O'Meara of Infectious Diseases has received an award (1R01-AI179141-01) from the National Institutes of Health for a project entitled "Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)." Total funding will be $5,510,650.
Nathan Thielman of Infectious Diseases has received an award (1R21-TW012650-01) from the National Institutes of Health for a project entitled "Adapting and Piloting an Evidence-based Intervention to Improve Hypertension Care among Tanzanians Living with HIV." Total funding will be $392,285.
Opeyemi Olabisi of Nephrology has received an award from the NEPHCURE Kidney International for a project entitled "Nephcure." Total funding will be $50,000.
Christina Barkauskas of Pulmonary has received a sub-award (1U01-HL168416-01) through the Intermountain Healthcare for a project entitled "ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (APS)." Total funding will be $26,933.
Industry Sponsored Clinical Trials
Camille Frazier-Mills of Cardiology has received an award from Medtronic, Inc. for a project entitled "Micra AV." Total funding will be $89,883.
Marat Fudim of Cardiology has received an award from Acorai AB for a project entitled "IMAGING CORE LABORATORY: HEMODYNAMICS CORE FOR ACORAI MLG." Total funding will be $241,164.
Marat Fudim of Cardiology has received an award from Owkin, Inc. for a project entitled "CONFIDENT-HFpEF Phase 1." Total funding will be $79,700.
Marat Fudim of Cardiology has received an award from Owkin, Inc. for a project entitled "SOLENOID PHASE 1." Total funding will be $78,700.
Mitchell Krucoff of Cardiology has received an award from Boston Scientific Corporation for a project entitled "2023 MDEpiNet dues." Total funding will be $35,000.
Renato Lopes of Cardiology has received an award from Cytokinetics, Inc. for a project entitled "CY 6033 CEC: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN COMPARED TO PLACEBO IN ADULTS WITH SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIO." Total funding will be $298,318.
Nishant Shah of Cardiology has received an award from Amgen, Inc. for a project entitled "cvMOBIUS 2." Total funding will be $46,941.
Andrew Wang of Cardiology has received an award from MyoKardia, Inc. for a project entitled "Symptomatic oHCM and MYK-224." Total funding will be $974,465.
Andrew Wang of Cardiology has received an award from MyoKardia, Inc. for a project entitled "Mavacamten & Symptomatic nHCM." Total funding will be $506,836.
Harry Erba of Cell Therapy has received an award from Gilead Sciences, Inc. for a project entitled "GS-US-546-5857." Total funding will be $377,036.
Thomas Leblanc of Cell Therapy has received an award from GlaxoSmithKline for a project entitled "Real-World Analysis of Belantamab Mafodotin Dosing Patterns in Patients with Relapsed and/or Refractory Multiple Myeloma." Total funding will be $218,659.
Lindsay Rein of Cell Therapy has received an award from PharmaEssentia USA Corporation for a project entitled "A22-301." Total funding will be $890,436.
Lindsay Rein of Cell Therapy has received an award from Imago BioSciences for a project entitled "IMG-7289-CTP-203." Total funding will be $278,498.
Andrew Muir of Gastroenterology has received an award from GlaxoSmithKline for a project entitled "Long-term safety and tolerability study of linerixibat for the treatment of cholestatic pruritus in participants with primary biliary cholangitis.." Total funding will be $63,347.
Lana Wahid of General Internal Medicine has received an award from Dompe Farmaceutici S.p.A. for a project entitled "Dompe REPAVID-22." Total funding will be $134,639.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 2 Randomized, Open-label Study to Evaluate the Safety and Efficacy of Broadly Neutralizing Antibodies (bNAbs) GS-5423 and GS-2872 in Combination With the Capsid Inhibitor Lenacapavir as Long-Acting Treatment Dosed Every 6 Months in Virologica." Total funding will be $1,063,697.
Carey Anders of Oncology has received an award from Incyclix Bio, LLC for a project entitled "Incyclix INX-315-01." Total funding will be $576,916.
Rani Bansal of Oncology has received an award from Context Therapeutics, Inc. for a project entitled "An Open-Label, Phase 1b-2 Study of Elacestrant, in Combination with Onapristone in Patients with Estrogen Receptor-Positive, Progesterone Receptor-Positive, HER2-negative Advanced or Metastatic Breast Cancer (ELONA." Total funding will be $7,500.
Jeffrey Clarke of Oncology has received an award from Amgen, Inc. for a project entitled "Amgen 20190341." Total funding will be $294,643.
Christopher Hoimes of Oncology has received an award from CRISPR Therapeutics for a project entitled "A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9?Engineered T Cells (CTX131) in Adult Subjects with Relapsed or Refractory Solid Tumors." Total funding will be $541,150.
Christopher Hoimes of Oncology has received an award from BioNTech SE for a project entitled "BionNTech BNT142-01 (CLDN6+ solid tumors)." Total funding will be $190,591.
Niharika Mettu of Oncology has received an award from Adanate, Inc. for a project entitled "A Phase 1, Open-Label, Multicenter Study of ADA-011 as Monotherapy and in Combination With Pembrolizumab for Subjects With Advanced Solid Tumors." Total funding will be $915,933.
Andrew Nixon of Oncology has received a sub-award through Alliance Foundation Trials, LLC for a project entitled "Circulating Protein Biomarker Analysis for women with HR-positive advanced breast cancer." Total funding will be $137,940.